When human W25I-labeled Factor Xa is incubated with washed platelets, prothrombin, and Ca2+, a small amount of thrombin is formed which causes the platelet release reaction after a period of time that decreases as the Xa concentration is increased from 0.9 to 19 ng/ml. After a further lag period, the Xa binds reversibly to receptors on the platelet surface and rapid thrombin formation follows (3 units The results suggest that specific receptors for Xa appear on the platelet surface after the release reaction occurs. The bound Xa catalyzes thrombin formation 1000-fold faster than does Xa added to reactions in which phospholipids are substituted for platelets.
The first stage in hemostasis is thought to be adhesion of platelets to subendothelial collagen or other substances at sites of injury. The platelet release reaction then occurs and secretion of numerous substances, including ADP and products of arachidonic acid transformation, is believed to promote further platelet aggregation with the eventual formation of a primary hemostatic plug. Later, fibrin accumulates to provide a more permanent arrest of bleeding. Understanding of the interactions between platelets and plasma coagulation factors in generating a fibrin clot is incomplete. Numerous investigators have observed that platelets accelerate the clotting of plasma (for review, see ref. 1). The term "platelet factor 3" historically has been used to describe this procoagulant activity, although neither its subcellular localization nor its chemical nature has been clearly defined (2) .
Factor Xa catalyzes the conversion of prothrombin to thrombin. Factor V, Ca2+, and phospholipid increase the rate of the reaction by organizing the enzyme and substrate into a lipoprotein complex (3). Milstone (4) showed that phospholipid and Factor V can replace platelets in prothrombin activation. Phospholipid can substitute for platelets in various assays that measure the clotting time of plasma as well, and it has been proposed that platelets may promote clotting by providing a phospholipid surface (5). Marcus et al. (6) suggested that more than phospholipid is involved because 20 times more extracted platelet phospholipid is required to achieve the same clotpromoting activity as that present in the intact membranes.
Experiments to measure the interaction of individual plasma coagulation factors with platelets require purified factors and
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Numerous experiments suggest that the first step in the action of thrombin on platelets is binding of thrombin to a specific cell surface receptor (7) (8) (9) (10) . We now report the first of our studies to determine if thrombin is actually formed on the platelet surface. We have measured the interaction of homogeneous '25I-labeled Factor X. ('25I-X.) with platelets and the effect of bound X. on thrombin generation. Jevons and Barton (11) demonstrated that bovine Xa caused platelet aggregation and release when the platelets were not washed free of plasma prothrombin. Undoubtedly this reaction was due to thrombin that was generated and then bound to its receptor. Our experiments demonstrate that platelets also have a distinct receptor for Xa that only appears on the platelet surface after the release reaction occurs.
MATERIALS AND METHODS
Platelets were isolated from human blood and washed to remove plasma as described previously (12) .
Human peripheral blood lymphocytes, provided by John Rogers, were stimulated with phytohemagglutinin, cultured for 5 days, and harvested in logarithmic growth (13 The X-coagulant protein was prepared from Russell's viper venom (19) . Human thrombin was isolated as described by Fenton et al. (20) after activation of the highly purified prothrombin by incubation with either Taipan snake venom or Xa in the presence of Ca2+ and rabbit brain cephalin.
Xa was formed by incubating Factor X with 0.1% (wt/wt) of the X-coagulant protein at 370 for 15 min in 0.15 M sodium chloride/0.01 M calcium chloride/0.02 M Tris, pH 7.4. Xa was isolated by chromatography on QAE-A50 developed with a linear sodium chloride gradient from 0.15-0.40 M. When 0.1 ml of 0.025 M calcium chloride, 0.1 ml of rabbit brain cephalin (400 sg/ml), 0.1 ml of Xa (10 ng/ml in 0.15 M sodium chloride/5.1 mM sodium citrate/7.1 mM sodium acetate/7.1 mM sodium diethyl barbiturate/bovine serum albumin, 10 mg/ml, adjusted to pH 7.4 with hydrochloric acid), and 0.1 ml of Factors VII-and X-deficient plasma were incubated at 370, the clotting time was 30 sec.
Factors X and Xa were labeled by a chloramine-T procedure (21) to a specific activity of 5,000-10,000 cpm/ng. No change in the clotting activity was detectable initially, although some loss of activity relative to unlabeled preparations was noted after 2-3 weeks.
Coagplation Assays. All assays were done in a Fibrometer (BBL). The method of Fenton and Fasco (22) for determining thrombin activity was modified to make the final assay volume 0.3 ml. Log-log plots were linear from final thrombin concentrations of 0.04 to 1.0 unit/ml, corresponding to clotting times of 160 to 15 sec.
Prothrombin and Factor X were assayed by standard methods (16, 23 (5 mg/ml), glucose (1 mg/ml), 0.14 M sodium chloride, 2.5 mM calcium chloride, and 0.02 M Tris at pH 7.4. Reaction mixtures contained 1 X 108 platelets per ml and 73 jig of prothrombin per ml (when added). After incubation in 12 X 75 mm Falcon tubes at 220, the platelet suspensions (0.5 ml) were carefully layered onto 0.5 ml of an oil mixture (1 part Apiezon, 9 parts n-butyl phthalate, specific gravity 1.029) in 1.5-ml Eppendorf conical centrifuge tubes. After centrifugation at 12,000 X g in a Brinkmann microcentrifuge for 2 min, 0.2 ml of supernatant was removed for determination of unbound 125I activity or released [14C]serotonin or both. The remaining liquid was aspirated and the tube (containing the platelet pellet) was cut off and its radioactivity was measured.
RESULTS
Binding of Factors X and Xa to Platelets. In preliminary experiments we attempted to measure the binding of 125I-labeled Factor X and its activated derivative, '25I-Xa, to washed human platelets by using both Millipore filtration and oil centrifugation, methods that have been used to demonstrate the binding of thrombin to platelets (7, 24) . No When the experiment shown in Fig. 1B was repeated in the presence of 200-fold excess (1.0 ,ug/ml) of unlabeled Factor X (zymogen), there was similar binding of 125I-Xa (0.7 ng per 108 platelets) and the rate of thrombin formation was also unaffected (2.4 units/ml per min). This result suggests that the zymogen, Factor X, does not bind to the platelet Xa receptor.
The '25I-Xa bound to platelets in these experiments appeared to be unaltered as determined by sodium dodecyl sulfate/ polyacrylamide gel electrophoresis (Fig. 2 ). The stained gel shows the Xa used for these experiments and the radiochromatogram shows the '25I radioactivity in the platelet pellet after Xa binding occurred. The peaks of radioactivity corresponded to the stained heavy and light chains of Xa. The small shoulder of radioactivity in the latter is a radioactive contaminant in the 125I-Xa that migrates with the tracking dye. When the same amount of 125I-Xa was applied directly to control gels, the recovery of radioactivity in the peaks and the pattern of migration were the same as in Fig. 2 . Xa Binds to Platelets Only after the Release Reaction Has Occurred. When platelets were treated with thrombin (0.5 units/ml), Xa binding sites were available (Fig. 3A) . In this experiment, the binding began immediately after addition of 125I-Xa ( 1. This result indicates that prothrombin is not essential for Xa binding to platelets. Ca2+ is required, and the optimal concentration of calcium chloride was 2.5 mM. Addition of prothrombin to the reaction mixtures after the Xa was bound resulted in immediate thrombin generation at high rates.
When platelets were incubated with 10 mM dibutyryl cyclic AMP for 20 min prior to addition of thrombin (0.5 unit/ml), the release reaction was inhibited by 50% as determined by measuring [14C]serotonin release. We then added 125-IXa and prothrombin and found that 125-IXa binding to these platelets was decreased by approximately 50% and thrombin formation was also 50% of the rate obtained with control platelets. This finding suggests that platelet binding sites for Xa appear as a result of the release reaction rather than from some other action of thrombin on the platelet surface. When [14C]serotonin release from platelets was stimulated by using calcium ionophore A23187, Xa binding sites appeared. In this experiment, platelet suspensions were incubated with either thrombin (0.5 unit/ml) or 1.0 AM A23187 for 15 min. 125I-X. (10 ng/ml) was then added and the binding of Xa was measured. Both treatments resulted in 1.4 ng of 125-IXa bound per 108 platelets in 20 min. Addition of prothrombin also resulted in immediate and rapid thrombin generation in both cases, indicating that thrombin itself is not specifically required.
Characteristics of Xa Receptor Sites. When 1000-fold excess unlabeled Xa was added (Fig. 3A) to platelets that had bound 1251-Xa, the labeled Xa was rapidly displaced, indicating that binding is reversible. This result suggests that Xa binds at the platelet surface, but direct demonstration of this point by electron microscopy/autoradiography, as was done in studies of the thrombin receptor (7), was impossible due to the small number of Xa binding sites per platelet (e.g., in Fig. 3, 1.3 ng of 1251-Xa bound per 108 platelets corresponds to only 170 Xa molecules per platelet).
When platelets were treated with thrombin at 50 units/ml for 0-50 min and then 10 ng of 125-IXa per ml was added for 10 min, there was a progressive decrease in 125I-Xa bound, from 0.9 ng per 108 platelets to 0.13 platelets (Fig. 3B) . The latter value is similar to the amount of 125-IXa not displaced by excess unlabeled Xa or bound in 10 min to platelets not treated with thrombin (Fig. 3A) and therefore may reflect binding not functionally related to the interaction investigated here. The decrease in Xa binding is not a result of platelet lysis. Less than 4% of the total lactic dehydrogenase activity of sonicated platelets was released from platelets treated with thrombin at 50 units/ml for 60 min. A likely explanation for this timedependent effect of thrombin is proteolysis of the Xa receptor, although another possibility is a conformational change in the membrane that masks Xa receptor sites. Prolonged treatment of platelets with thrombin at 0.5 unit/ml did not affect 125I-Xa binding. This experiment also shows that thrombin does not compete with Xa for binding because the same amount of; 1251-X. was initially bound in the presence of thrombin at 0.5 or 50 units/ml (Fig. 3B, 0 time) . In the latter case, the thrombin concentration was 0.5 WM, a 2500-fold molar excess over '25I-Xa (0.2 nM).
Function of Xa Bound to Platelets. The time course of increased thrombin formation shown in Fig. 1 suggested that the lZ5'-Xa bound to platelets accounts for the accelerated prothrombin activation. To determine if Xa must be associated with the platelets to convert prothrombin to thrombin at significant rates, the platelets had to be effectively removed from the reaction mixture. We treated platelets with thrombin at 0.5 unit/ml as outlined in Fig. 3 and then incubated them for 20 min with '25I-Xa (10 ng/ml). Platelets were separated from one portion of this reaction mixture by centrifugation through oil. The supernatant from this reaction mixture was further centrifuged for 10 min at 165,000 X g in a Beckman Airfuge to remove any platelet fragments. Another portion of the original Medical Sciences: Miletich et al. 4036 Medical Sciences: Miletich et al.
reaction mixture was centrifuged at 2400 X g for 10 min, the supernatant was removed, and the pellet of aggregated platelets was resuspended in buffer. Prothrombin was then added to the high-speed supernatant solution, the resuspended pellet, and a portion of the original unspun reaction mixture. The maximal rate of thrombin generation was 2.5 units/ml per min in the original unspun mixture, 0.8 in the resuspended pellet, and 0.006 in the supernatant fraction. The 125I-Xa in the supernatant fraction (9.3 ng/ml) was assayed and found to be fully active. This experiment indicates that prothrombin activation is catalyzed by the Xa that is bound to platelets.
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